<DOC>
	<DOC>NCT00516451</DOC>
	<brief_summary>The purpose of this clinical study is to identify the maximum tolerated dose (MTD) of BMS-690514 once daily orally in Japanese subjects with advanced or metastatic solid tumors.</brief_summary>
	<brief_title>Phase I Study of BMS-690514 in Japanese Patients With Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Subjects with advanced or metastatic solid tumors for whom the standard of care is ineffective or inappropriate, with adequate kidney, liver and cardiac function.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2008</verification_date>
</DOC>